Analysis of Adenoviral Transport Mechanisms in the Vessel Wall and Optimization of Gene Transfer Using Local Delivery Catheters
- 20 January 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (2) , 237-246
- https://doi.org/10.1089/10430340050015987
Abstract
Local delivery devices have been used for adenovirus-mediated gene transfer to the arterial wall for the potential treatment of vascular proliferative diseases. However, low levels of adenoviral gene expression in vascular smooth muscle cells may pose a serious limitation to the success of these procedures in the clinic. In this study, we examined the mechanisms controlling adenoviral transport to the vessel wall, using both hydrogelcoated and infusion-based local delivery catheters, with the goal of enhancing in vivo gene transfer under clinically relevant delivery conditions. The following delivery parameters were tested in vivo: applied transmural pressure, viral solution volume and concentration, and delivery time. We found that viral particles are transported into the vessel wall in a manner consistent with diffusion rather than pressure-driven convection. Consistent with diffusion, viral concentration was shown to be the key variable for viral transport in the vessel wall and thus gene expression in vascular smooth muscle cells. A transduction level of 17.8 +/- 3.2% was achieved by delivering a low volume of concentrated adenoviral beta-galactosidase solution through an infusion balloon catheter at low pressure without an adverse effect on medial cellularity. Under these conditions, effective gene transfer was accomplished within a clinically relevant time frame of 2 min, indicating that longer delivery times may not be necessary to achieve efficient gene transfer.Keywords
This publication has 33 references indexed in Scilit:
- Early Cell Loss after Angioplasty Results in a Disproportionate Decrease in Percutaneous Gene Transfer to the Vessel WallHuman Gene Therapy, 1999
- Effects of Poloxamer 407 on Transfection Time and Percutaneous Adenovirus-Mediated Gene Transfer in Native and Stented VesselsHuman Gene Therapy, 1998
- Optimal techniques for arterial gene transferCardiovascular Research, 1997
- Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplastyCardiovascular Research, 1997
- Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectorsGene Therapy, 1997
- Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries.Journal of Clinical Investigation, 1996
- Pharmacokinetics of Adenoviral Vector-Mediated Gene Delivery to Vascular Smooth Muscle Cells: Modulation by Poloxamer 407 and Implications for Cardiovascular Gene TherapyHuman Gene Therapy, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The distribution of labeled low-density lipoproteins across the rabbit thoracic aorta in vivoAtherosclerosis, 1977